Analysts/Institutional Investor Meet/Con. Call Updates
- High trailing return on capital (ROCE 30.0%) and record FY26 net profit of ₹104 Cr.
- Targeted 5% reduction in egg production costs via ₹70 Cr EC shed and biogas plant project.
- Domestic revenue diversification via 'SKM Best Eggs' adding ₹40-50 Cr high-margin revenue in FY27.
- Long-term growth visibility from 5x layer bird expansion (4 lakh to 24 lakh birds) targeting completion by Dec 2028.
- Attractively valued at 8.3x trailing P/E relative to peer median P/E of 16.4x.
- High earnings volatility due to exposure to international egg powder prices and FX fluctuations.
- Substantial leverage increase expected as company raises ₹300 Cr debt to fund the ₹400 Cr expansion.
- Geographic and customer concentration with 45% of exports directed to Japan and Russia.
- Biosecurity risks including Avian Influenza (bird flu) which could disrupt supply or trigger export bans.
Executive Summary
SKM Egg Products (SKMEGGPROD) presents an intriguing combination of high current profitability (FY26 PAT ₹104 Cr, ROCE 30%) and ambitious expansion plans. The analyst update on 2026-07-31 detailed an ongoing ₹70 Cr capex for Environmentally Controlled (EC) sheds and a biogas plant expected to yield a 5% cost reduction, alongside a ₹40-50 Cr incremental revenue contribution from domestic branded eggs in FY27. Furthermore, the company is advancing a mega ₹400 Cr expansion to scale bird capacity 5x to 24 lakh birds by Nov-Dec 2028. However, because the core ₹400 Cr capex plan was already formally disclosed in May 2026, today's update is largely incremental and already partially priced into the stock (up 85% in 12m).
1. Ramp-Aware Impact Analysis
- Immediate FY27 Impact: The ₹40-50 Cr branded egg revenue contribution adds ~5.9% to TTM revenue (₹768 Cr). With the 5% reduction in egg production costs, operating margin (OPM) should expand by ~100-150 bps, adding approximately ₹8-10 Cr to net profit in FY27 (EPS boost of ~₹2.5 to ₹35.7).
- Long-Term Mega Capex (Nov-Dec 2028 completion): The full expansion adds 20 lakh birds (5x capacity increase). Execution spans ~2.5 years (FY27–FY29).
- Steady-State Math (FY29): Assuming ₹300 Cr incremental revenue at steady state (+39% uplift over FY26) and 18-20% OPM, incremental operating profit would be ~₹55-60 Cr. After accounting for interest costs on ₹300 Cr incremental debt (~₹27 Cr at 9% p.a.), steady-state PAT increases by ~₹25-30 Cr (+25-30% EPS uplift over FY26 base).
2. Industry Context & Operational Difficulty
- Capital Intensity: Medium-to-High. Poultry integration requires significant civil structure, biosecurity infrastructure, and automated feed handling.
- Execution Difficulty: Medium. Managing bird health, biosecurity, and flock cycles over a 2.5-year construction ramp carries non-trivial execution risk.
- Industry Growth: The domestic processed egg and hygienic protein market in India is expanding at ~10% CAGR, driven by institutional and QSR demand.
3. Financial Quality & Volatility Check
- Earnings Cyclicality: SKM's earnings are highly sensitive to global commodity cycles. FY24 PAT was ₹85 Cr, FY25 PAT dropped to ₹34.6 Cr due to pricing pressure and volume drops, before surging to ₹104 Cr in FY26.
- Balance Sheet & Leverage: Current D/E is moderate at 0.36x (Debt ₹141 Cr on Net Worth ₹396 Cr). Raising ₹300 Cr debt for the mega capex will elevate D/E to ~0.9-1.0x, raising interest coverage sensitivity during cyclical down-cycles.
4. Valuation Scenarios (24-36 Month Horizon)
- Base Case (₹400 / +45%): Company delivers ₹40-50 Cr domestic uplift in FY27, maintains 18-20% OPMs, and executes the EC shed project smoothly. EPS reaches ₹42-45 by FY28; P/E re-rates modestly from 8.3x to 10-11x.
- Bull Case (₹520 / +90%): Flawless execution of the 20-lakh bird expansion, sustained global egg powder pricing, and rapid market penetration of 'SKM Best Eggs'. EPS reaches ₹52+; P/E re-rates toward industry peer average (~14-16x).
- Bear Case (₹192 / -30%): Global egg price downturn or regional Avian Influenza outbreak coincides with elevated debt levels (₹300 Cr debt load). PAT contracts back to FY25 levels (~₹35-40 Cr), suppressing stock valuation.
5. Verdict Rationale
SKM Egg Products is rated POSSIBLE (Multibagger Score: 58/100). While current ROCE (30%) and low trailing valuation (8.3x P/E) offer an attractive starting point, the high cyclicality of processed egg prices, biosecurity vulnerabilities, and significant leverage increase required for the ₹400 Cr expansion prevent a 'STRONG_CANDIDATE' classification.